Angelini Pharma Enters Into An Exclusive Option Agreement With Cureverse to License Global Development and Commercialization Rights For A Novel and Innovative Clinical-Stage Brain Health Asset October 22, 2024
Articul8 AI Signs Strategic Collaboration Agreement with AWS to Deliver Generative AI Solutions to Enterprises October 16, 2024